- Filed
- Nov 12, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 8, 2021 | 2.93M sh |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $15.07M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $32.35M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2020 | $21.87M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2019 | $37.74M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $206.03M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $195.63M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $248.46M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $237.13M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $36.75K |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $97.14K |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $38.48K |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $108.02K |
| Shares Diluted restated | Q3 2021 · Sep 30, 2020 | 2.79M sh |
| Shares Diluted restated | Q3 2021 · Sep 30, 2020 | 2.79M sh |
| Capex | Q3 2021 · Sep 30, 2020 | $305.57K |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | −$12.68M |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | $39.74M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | $38.74M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | $23.84M |
| Eps Diluted restated | Q3 2021 · Sep 30, 2020 | $0.33 |
| Eps Diluted restated | Q3 2021 · Sep 30, 2020 | $0.51 |
| Eps Basic restated | Q3 2021 · Sep 30, 2020 | $0.34 |
| Eps Basic restated | Q3 2021 · Sep 30, 2020 | $0.52 |
| Net Income | Q3 2021 · Sep 30, 2020 | $938.53K |
| Net Income | Q3 2021 · Sep 30, 2020 | $1.44M |